- Home
- KURA vs AGS Comparison
KURA vs AGS Comparison
Compare KURA & AGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- AGS
- Stock Information
- Founded
- KURA 2014
- AGS 2005
- Country
- KURA United States
- AGS United States
- Employees
- KURA N/A
- AGS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- AGS Miscellaneous manufacturing industries
- Sector
- KURA Health Care
- AGS Consumer Discretionary
- Exchange
- KURA Nasdaq
- AGS Nasdaq
- Market Cap
- KURA 492.9M
- AGS 508.0M
- IPO Year
- KURA N/A
- AGS 2018
- Fundamental
- Price
- KURA $5.85
- AGS $12.38
- Analyst Decision
- KURA Strong Buy
- AGS Hold
- Analyst Count
- KURA 12
- AGS 1
- Target Price
- KURA $24.50
- AGS $12.50
- AVG Volume (30 Days)
- KURA 1.3M
- AGS 427.4K
- Earning Date
- KURA 08-07-2025
- AGS 08-06-2025
- Dividend Yield
- KURA N/A
- AGS N/A
- EPS Growth
- KURA N/A
- AGS 852.53
- EPS
- KURA N/A
- AGS 1.16
- Revenue
- KURA $67,991,000.00
- AGS $393,717,000.00
- Revenue This Year
- KURA $109.86
- AGS $4.30
- Revenue Next Year
- KURA $107.90
- AGS $5.14
- P/E Ratio
- KURA N/A
- AGS $10.68
- Revenue Growth
- KURA N/A
- AGS 6.60
- 52 Week Low
- KURA $5.41
- AGS $11.09
- 52 Week High
- KURA $23.48
- AGS $12.41
- Technical
- Relative Strength Index (RSI)
- KURA 40.44
- AGS 67.73
- Support Level
- KURA $5.56
- AGS $12.36
- Resistance Level
- KURA $7.17
- AGS $12.40
- Average True Range (ATR)
- KURA 0.38
- AGS 0.04
- MACD
- KURA -0.06
- AGS -0.00
- Stochastic Oscillator
- KURA 6.05
- AGS 86.05
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.